AB-Biotics S.A. | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,529.20
2,274.80
1,314.50
2,796.60
924.20
577.30
Depreciation, Depletion & Amortization
698.50
770.30
773.50
1,089.70
1,137.30
1,190.50
Other Funds
295.20
204.20
-
4,882.70
249.70
714
Funds from Operations
1,449.90
1,227.10
851.40
1,300.10
452.30
2,481.70
Changes in Working Capital
100.60
121.50
967.60
275.90
146.10
1,518.20
Net Operating Cash Flow
1,349.30
1,348.70
116.10
1,576.00
306.20
963.50
Capital Expenditures
611.10
933.00
1,241.90
1,517.60
689.20
Purchase/Sale of Investments
2,612.90
1,956.70
643.10
22.30
180.70
Net Investing Cash Flow
3,224.00
1,023.60
598.80
1,779.80
112.20
Issuance/Reduction of Debt, Net
541.80
113.70
321.70
596.50
654.90
Net Financing Cash Flow
1,092.70
89.30
49.10
5,439.50
451.70
Net Change in Cash
3,480.60
235.70
433.70
2,083.70
257.80
Free Cash Flow
1,364.20
1,421.90
78.80
1,576.00
284.70
Other Sources
-
-
-
-
757.70
Change in Capital Stock
846.00
179.70
272.60
39.70
46.60
Other Uses
-
-
-
239.90
-

About AB-Biotics

View Profile
Address
Esade Creapolis
Barcelona Catalonia 08172
Spain
Employees -
Website http://www.ab-biotics.com
Updated 07/08/2019
AB-Biotics SA engages in the research, development, innovation, and production of biotechnological solutions. It operates through the Probiotics and Genetic Tests business areas. The Probiotics business area offers probiotics for cardiometabolic, oral care, pediatrics, gastrointestinal health, gynaecology and urology, and dermatology and immunology.